Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Quantum looks to capitalize on rapid growth
April 2017
SHARING OPTIONS:

PARIS—Quantum Genomics, a biopharmaceutical company focused on developing therapies to address unmet medical needs with a focus on cardiovascular disease, is seeking to maintain its momentum of late, having announced that it has joined the Pass French Tech program of the 2016-2017 selection. The program, which is intended for “hyper-growth companies,” aims to offer services to such companies to address issues linked with hyper-growth, which includes access to funding and supporting international development. To this end, the Pass French Tech program leverages the services of a variety of institutions, including an innovation bank, a patents institute, a corporations management committee and companies that specialize in international development and export insurance.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.